Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes.
Agostini H, Abreu F, Baumal CR, Chang DS, G Csaky K, Demetriades AM, Kodjikian L, Lim JI, Margaron P, Monés JM, Peto T, Ricci F, Rüth M, Singh RP, Stoilov I, Swaminathan B, Willis JR, Westenskow PD. Agostini H, et al. Among authors: stoilov i. Graefes Arch Clin Exp Ophthalmol. 2024 Nov;262(11):3437-3451. doi: 10.1007/s00417-024-06531-9. Epub 2024 Jun 7. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 38847896 Free PMC article. Review.
Disease Activity Criteria Impact Dosing Interval Assignment in nAMD Trials.
Zarbin MA, Weng CY, London NJS, Koh AHC, Gallego-Pinazo R, Chaudhary V, Souverain A, Stoilov I, Margaron P. Zarbin MA, et al. Among authors: stoilov i. Ophthalmol Retina. 2024 Dec 27:S2468-6530(24)00617-1. doi: 10.1016/j.oret.2024.12.021. Online ahead of print. Ophthalmol Retina. 2024. PMID: 39733838 Free article. No abstract available.
60 results